Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: A randomized, double-blind phase III trial Academic Article uri icon

Overview

MeSH Major

  • Piperidines
  • Quinazolines
  • Thyroid Neoplasms

abstract

  • Vandetanib demonstrated therapeutic efficacy in a phase III trial of patients with advanced MTC (ClinicalTrials.gov NCT00410761).

publication date

  • January 10, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3675689

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.35.5040

PubMed ID

  • 22025146

Additional Document Info

start page

  • 134

end page

  • 41

volume

  • 30

number

  • 2